
    
      PediaBerry™ is a proprietary blend of powdered berry extracts. Placebo: powdered sugar plus
      McCormick Color from Nature Food Colors Berry and Sky Blue powdered food color
      (https://www.mccormick.com/spices-and-flavors/extracts-and-food-colors/food-colors/color-from
      -nature-assorted-food-color ).

      Cream vehicle is mixed with PediaBerry™ or placebo at the time of application.Children will
      receive once daily topical and oral gavage dosing of PediaBerry or placebo.

      The first study visit will take place within 2 weeks of subject recruitment. The subject
      enrollment, consenting and randomization will occur as study visit #0 and will occur at Riley
      Children's Hospital or Nationwide Children's Hospital. Data collection will be the same at
      all study visits starting with study visit #1 until the completion of the study. The first
      dose of PediaBerry™ or placebo will be administered prior to completion of study visit #1,
      and will also be given at study visits #2-6. Study visits #2-6 will occur monthly study
      visits until the subject completes 6 months of treatment.Subjects will be weighed and
      treatment doses adjusted accordingly. Study visits #7-11 to watch for signs of rebound
      hemangioma proliferation will occur every other month until age 12 months and then at age 15
      and 18 months. Urine samples, photos and caliper measurements will occur at each study visit.
      Some subjects may have less than 11 study visits depending on the age at the time of subject
      enrollment.
    
  